Trinity Biotech plc (NASDAQ:TRIB) headquartered in Bray, will host a conference call for the investment community to discuss the 3Q20 financial results on 17th November 2020 at 11:00 AM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.trinitybiotech.com
To participate on the live call, please dial 1-844-861-5499 or 1-412-317-6581 (International)
Earnings Expectation
Trinity Biotech plc manufacturer of medical diagnostic products, is expected to report third quarter earnings results, before market open, on Tuesday 17th November 2020.
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease, sexually transmitted diseases, respiratory infections, epstein barr virus, and other viral pathogens; and products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a high risk of developing diabetes. It also develops, manufactures, and distributes products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia.
